NO976094L - Nye peptider avledet av humant varmesjokkprotein 60 for behandling av diabetes, fremgangsmåte og sett - Google Patents

Nye peptider avledet av humant varmesjokkprotein 60 for behandling av diabetes, fremgangsmåte og sett

Info

Publication number: NO976094L
Authority: NO; Norway
Prior art keywords: diabetes; kit; treatment; heat shock; shock protein
Prior art date: 1995-06-30

Application number

NO976094A

Other languages

English (en)

Other versions

NO976094D0 (no

NO320715B1 (no

Inventor

Irun R Cohen

Dana Elias

Rivka Abulafia

Jana Bockova

Original Assignee

Yeda Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-30

Filing date

1997-12-29

Publication date

1998-02-02

1997-12-29 Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev

1997-12-29 Publication of NO976094D0 publication Critical patent/NO976094D0/no

1998-02-02 Publication of NO976094L publication Critical patent/NO976094L/no

2006-01-23 Publication of NO320715B1 publication Critical patent/NO320715B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/80—Fluorescent dyes, e.g. rhodamine
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/804—Radioisotope, e.g. radioimmunoassay
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/808—Automated or kit

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Diabetes (AREA)
Animal Behavior & Ethology (AREA)
Genetics & Genomics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Endocrinology (AREA)
Hematology (AREA)
Immunology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO19976094A 1995-06-30 1997-12-29 Nye peptider avledet av humant varmesjokkprotein 60, farmasoytiske preparater omfattende slike og anvendelse av de nye peptider for fremstilling av farmasoytiske preparater for behandling og forebyggelse av insulinavhengig diabetes mellitus, samt fremgangsmate og sett for diagnostisering av IDDM. NO320715B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IL11440795A IL114407A0 (en)	1995-06-30	1995-06-30	Novel peptides and pharmaceutical compositions comprising them
PCT/US1996/011375 WO1997001959A1 (en)	1995-06-30	1996-07-01	Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits

Publications (3)

Publication Number	Publication Date
NO976094D0 NO976094D0 (no)	1997-12-29
NO976094L true NO976094L (no)	1998-02-02
NO320715B1 NO320715B1 (no)	2006-01-23

Family

ID=11067704

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19976094A NO320715B1 (no)	1995-06-30	1997-12-29	Nye peptider avledet av humant varmesjokkprotein 60, farmasoytiske preparater omfattende slike og anvendelse av de nye peptider for fremstilling av farmasoytiske preparater for behandling og forebyggelse av insulinavhengig diabetes mellitus, samt fremgangsmate og sett for diagnostisering av IDDM.

Country Status (19)

Country	Link
US (1)	US6682897B1 (no)
EP (1)	EP0845943B1 (no)
KR (1)	KR100454554B1 (no)
CN (1)	CN1102598C (no)
AR (1)	AR003446A1 (no)
AT (1)	ATE290315T1 (no)
AU (1)	AU710882B2 (no)
CA (1)	CA2225675C (no)
CZ (1)	CZ295110B6 (no)
DE (1)	DE69634438T2 (no)
DK (1)	DK0845943T3 (no)
ES (1)	ES2239770T3 (no)
HR (1)	HRP960307A2 (no)
HU (1)	HUP9901688A3 (no)
IL (2)	IL114407A0 (no)
NO (1)	NO320715B1 (no)
UY (1)	UY24270A1 (no)
WO (1)	WO1997001959A1 (no)
ZA (1)	ZA965565B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6488933B2 (en)	1995-07-05	2002-12-03	Yeda Research And Development Co. Ltd.	Preparations for the treatment of T cell mediated diseases
WO1997043649A1 (en) *	1996-05-14	1997-11-20	Winnacker Ernst Ludwig	CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrP?sc¿
US5993803A (en) *	1996-08-30	1999-11-30	Yeda Research And Development Co., Ltd.	Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity
EP1237570A4 (en) *	1999-12-15	2005-01-05	Peptor Ltd	FRAGMENTS AND ANTAGONISTS OF THERMAL SHOCK PROTEINS 60
EP1335741A4 (en) *	2000-08-25	2005-10-26	Yeda Res & Dev	METHOD FOR THE PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDES (04.03.02)
WO2003063759A2 (en)	2002-01-31	2003-08-07	Peptor Ltd.	Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
WO2003070761A1 (en) *	2002-02-19	2003-08-28	Yeda Research And Development Co. Ltd.	Dual-effect ligands comprising anti-inflammatory hsp peptide epitopes for immunomodulation
ES2433915T3 (es)	2002-05-21	2013-12-13	Irun R. Cohen	Vacunas de ADN que codifican proteínas de choque térmico
WO2004098489A2 (en) *	2003-05-12	2004-11-18	Peptor Ltd.	Compositions and methods for modulation of specific epitopes of hsp60
WO2005048914A2 (en) *	2003-11-24	2005-06-02	Yeda Research & Development Co. Ltd.	Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases
EP1718158B1 (en)	2004-01-28	2014-07-02	Andromeda Bio Tech Ltd.	Hsp therapy in conjunction with a low antigenicity diet
US8691772B2 (en)	2005-01-04	2014-04-08	Yeda Research And Development Co. Ltd.	HSP60, HSP60 peptides and T cell vaccines for immunomodulation
CU23701A1 (es) *	2008-12-29	2011-09-21	Ct Ingenieria Genetica Biotech	Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
KR101307132B1 (ko) *	2010-02-04	2013-09-10	이화여자대학교 산학협력단	비정상적 세포 증식 억제용 약제학적 조성물
ITCO20120007A1 (it)	2012-02-21	2013-08-22	Nuovo Pignone Srl	Dispositivo di filtraggio dell'aria in ingresso per un impianto
WO2013128450A1 (en)	2012-03-01	2013-09-06	Yeda Research And Development Co. Ltd.	Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes
WO2013128453A1 (en)	2012-03-01	2013-09-06	Yeda Research And Development Co. Ltd.	Regeneration of islet beta cells by hsp60 derived peptides
EP3448415A4 (en) *	2016-04-29	2019-11-06	Araim Pharmaceuticals, Inc.	TREATMENT-PROOFING PEPTIDES FOR THE PREVENTION AND TREATMENT OF DISEASES AND DISORDERS RELATED TO TISSUE DAMAGE
CN111035755B (zh) *	2020-01-08	2023-04-14	中国医学科学院医学生物学研究所	一种1型糖尿病疫苗及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5242823A (en) *	1986-03-07	1993-09-07	International Genetic Engineering, Inc.	Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen
US4976958A (en) *	1987-02-26	1990-12-11	Scripps Clinic And Research Foundation	Mycobacterial recombinants and peptides
US5114844A (en) *	1989-03-14	1992-05-19	Yeda Research And Development Co., Ltd.	Diagnosis and treatment of insulin dependent diabetes mellitus

1995
- 1995-06-30 IL IL11440795A patent/IL114407A0/xx unknown
1996
- 1996-06-28 UY UY24270A patent/UY24270A1/es unknown
- 1996-07-01 HU HU9901688A patent/HUP9901688A3/hu not_active Application Discontinuation
- 1996-07-01 CA CA2225675A patent/CA2225675C/en not_active Expired - Lifetime
- 1996-07-01 CN CN96196403A patent/CN1102598C/zh not_active Expired - Lifetime
- 1996-07-01 CZ CZ19974117A patent/CZ295110B6/cs not_active IP Right Cessation
- 1996-07-01 AR ARP960103410A patent/AR003446A1/es not_active Application Discontinuation
- 1996-07-01 ES ES96924372T patent/ES2239770T3/es not_active Expired - Lifetime
- 1996-07-01 EP EP96924372A patent/EP0845943B1/en not_active Expired - Lifetime
- 1996-07-01 ZA ZA9605565A patent/ZA965565B/xx unknown
- 1996-07-01 IL IL12275796A patent/IL122757A/en not_active IP Right Cessation
- 1996-07-01 KR KR1019970709962A patent/KR100454554B1/ko not_active Expired - Fee Related
- 1996-07-01 AT AT96924372T patent/ATE290315T1/de active
- 1996-07-01 DE DE69634438T patent/DE69634438T2/de not_active Expired - Lifetime
- 1996-07-01 DK DK96924372T patent/DK0845943T3/da active
- 1996-07-01 HR HR114407A patent/HRP960307A2/hr not_active Application Discontinuation
- 1996-07-01 WO PCT/US1996/011375 patent/WO1997001959A1/en not_active Ceased
- 1996-07-01 AU AU64845/96A patent/AU710882B2/en not_active Expired
1997
- 1997-12-29 NO NO19976094A patent/NO320715B1/no not_active IP Right Cessation
2000
- 2000-07-11 US US09/613,743 patent/US6682897B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP3955627B2 (ja)	2007-08-08
AU6484596A (en)	1997-02-05
EP0845943A1 (en)	1998-06-10
AR003446A1 (es)	1998-08-05
CA2225675A1 (en)	1997-01-23
DE69634438T2 (de)	2006-02-09
ES2239770T3 (es)	2005-10-01
IL122757A0 (en)	1998-08-16
CN1193889A (zh)	1998-09-23
UY24270A1 (es)	2000-12-29
IL122757A (en)	2001-07-24
NO976094D0 (no)	1997-12-29
IL114407A0 (en)	1995-10-31
EP0845943A4 (en)	2002-04-10
CZ411797A3 (cs)	1998-06-17
KR100454554B1 (ko)	2005-04-06
JPH11509196A (ja)	1999-08-17
CA2225675C (en)	2010-09-21
WO1997001959A1 (en)	1997-01-23
EP0845943B1 (en)	2005-03-09
HUP9901688A2 (hu)	1999-09-28
CZ295110B6 (cs)	2005-05-18
AU710882B2 (en)	1999-09-30
ZA965565B (en)	1997-02-26
ATE290315T1 (de)	2005-03-15
HRP960307A2 (en)	1998-04-30
MX9800191A (es)	1998-05-31
DK0845943T3 (da)	2005-07-11
DE69634438D1 (de)	2005-04-14
US6682897B1 (en)	2004-01-27
CN1102598C (zh)	2003-03-05
KR19990028640A (ko)	1999-04-15
NO320715B1 (no)	2006-01-23
HUP9901688A3 (en)	1999-12-28

Publication	Publication Date	Title
NO976094L (no)	1998-02-02	Nye peptider avledet av humant varmesjokkprotein 60 for behandling av diabetes, fremgangsmåte og sett
NO976063D0 (no)	1997-12-23	Fremgangsmåte for behandling av diabetes
DK0833649T3 (da)	2003-04-07	Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier og fremgangsmåder til fremstilling og anvendelser deraf
DE69636760D1 (de)	2007-01-25	Rekombinanter anti-cd4 antikörper zur menschlichen behandlung
NO986089D0 (no)	1998-12-23	Metoder og preparater for behandling av tumorer, tumorrelaterte sykdommer o
IS4343A (is)	1996-12-09	Einstofna offitu (Ob) prótín
LV11615A (lv)	1996-12-20	Amidi ar arstnieciskam ipasibam
NO961006D0 (no)	1996-03-12	Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
DE69630479D1 (de)	2003-12-04	Arzneimittel zur Behandlung von entzündlichen Herzkrankheiten
NO20052755L (no)	2000-01-17	Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat, fremgangsmate for dens fremstilling og dens anvendelse.
FI952721L (fi)	1995-12-04	Aine maksa-sappi-sairauksien hoitamiseksi
ZA966240B (en)	1998-01-23	Methods for treatment of allergic asthma.
DE69635708D1 (de)	2006-03-30	Tetrandrin zur behandlung von augenentzündungen
NO20001869L (no)	2000-06-14	FremgangsmÕte for behandling av Alzheimers sykdom
EP1039883A4 (en)	2001-09-26	METHOD FOR TREATING APOLIPOPROTEIN E CONDITIONAL DISEASES
IS4957A (is)	1999-01-26	Hreinsuð prótein, samskeyttar DNA raðir og aðferðir til að stýra þroskun kaffiplantna
DE69735417D1 (de)	2006-05-04	2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
NO973193D0 (no)	1997-07-09	Kollagen-baserte metoder og formuleringer for behandling av immune system-medierte sykdommer
HUP9901204A3 (en)	2000-06-28	Novel protein hmw human mp52
NO980375D0 (no)	1998-01-28	Humant MP52 Arg protein
NO960766D0 (no)	1996-02-26	Nytt protein og fremgangsmåte for fremstilling av dette
NO952411D0 (no)	1995-06-16	Midler for behandling av metaboliske bensykdommer
EP0780472A3 (en)	1998-05-20	Stress proteins
AU7478098A (en)	1998-12-08	Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
HUP9903978A3 (en)	2001-01-29	Use of inhibitors of protein glycation for the treatment of type ii diabetes

Legal Events

Date	Code	Title	Description
2016-07-11	MK1K	Patent expired